Scott McClellan
About Scott McClellan
Scott McClellan is the Team Lead of Clinical Development at Orca Bio, with extensive experience in oncology and malignant hematology.
Scott McClellan at Orca Bio
Scott McClellan joined Orca Bio in 2018 and serves as the Team Lead of Clinical Development. His role involves overseeing development programs targeted at innovative therapies in oncology and malignant hematology. With over a decade of specialized experience, McClellan brings extensive expertise to the team, contributing significantly to the clinical strategy and execution of Orca Bio's pipeline.
Scott McClellan's Professional Background
Scott McClellan has a rich background in clinical development and oncology. Before his current role at Orca Bio, he was a Medical Director at Genentech, where he focused on early clinical development in oncology. During his tenure, McClellan led various clinical programs that evaluated T cell-directing bispecific antibodies and antibody-drug conjugates aimed at treating lymphoma and multiple myeloma.
Education and Expertise of Scott McClellan
Scott McClellan holds a bachelor's degree in biology from Birmingham-Southern College. He graduated with an MD and a PhD in immunology from Washington University in St. Louis School of Medicine. His comprehensive educational background underpins his expertise in hematology and oncology, which he further honed during his residency and fellowship at Stanford University School of Medicine.
Scott McClellan's Academic Contributions
In addition to his clinical roles, Scott McClellan was an Adjunct Clinical Assistant Professor of Medicine at Stanford University. He treated patients in the hematology clinic at the Palo Alto VA Hospital and conducted research on acute lymphoblastic leukemia. This academic involvement has reinforced his contributions to both the clinical and educational spheres of hematology and oncology.